Entries by CAPTIS

ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been The post ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors appeared first on Pharmaceutical Business review.

Schott to invest €300m in pharmaceutical packaging buisness

Through the investment, Schott plans to expand its primary business of glass tubing, used as the starting material for pharmaceutical packaging, and also pharmaceutical packaging made of glass and The post Schott to invest €300m in pharmaceutical packaging buisness appeared first on Pharmaceutical Business review.

Abbott inks deal to test blood donations in Japan

Abbott (NYSE:ABT) said today that it has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country’s blood donations. The eight-year contract is for the exclusive supply of serological instrumentation, tests, and consumables used for blood and plasma screening. The JRC screens approximately 5 million blood donations each year, helping ensure a […]

Windgap Medical raises $12m for epinephrine auto-injector

Windgap Medical has raised $12 million from 106 investors as part of a $27 million round, according to a document filed with the SEC. The Watertown, Mass.-based company is developing an epinephrine auto-injector designed to treat severe allergic reactions. Get the full story at our sister site, Drug Delivery Business News. The post Windgap Medical raises $12m for […]

HighLife raises $36m Series B for mitral valve replacement

HighLife said today that it raised a Series B round worth more than $36 million for the transcatheter mitral valve replacement it’s developing. HighLife’s TMVR uses a ring around the diseased valve’s leaflets that’s designed to guide the replacement valve into position. It’s designed to be delivered through the inter-atrial septum, rather than via a trans-apical […]

LivaNova touts studies of its sutureless aortic valve

LivaNova (NSDQ:LIVN) said today that three separate, recently published studies highlight the performance and cost savings of its sutureless aortic valve, Perceval. The results from the Perceval Aortic Heart Valve Study in North America found that Perceval achieves positive safety and efficacy outcomes whether or not an open or minimally invasive surgical approach is used. The […]

OtoNexus raises $4.4 million for ear infection detection technology

OtoNexus (Seattle) has raised more than $4.4 million as it continues to develop its ultrasound medical device technology to diagnose middle ear infections, according to a U.S. Securities and Exchange Commission Form D filed this month. OtoNexus has been seeking a nearly $8.3 million from the money-raise. It previously raised $7.8 million in 2017. Get the full […]

Johnson & Johnson, Apple ink collab for AFib study

Johnson & Johnson‘s (NYSE:JNJ) Janssen and Apple (NSDQ:AAPL) said today that the two companies inked a deal to study if an app from J&J in combination with the Apple Watch’s ECG app and irregular rhythm notifications can improve outcomes for people living with atrial fibrillation. The study is slated to measure the impact of the Apple Watch on the […]